Figure 2.
Risk of bias summery of the included randomized controlled trials (RCTs) according to the bias assessment tool of the Cochrane Collaboration. Performance bias for Diamond et al. (2015) was considered as low risk for letrozole versus clomiphene citrate (CC) and as unclear risk for the other two comparisons.